NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
Buyer: NHS England
- Published
- 21 March 2025
- Estimated value
- £1,516,353,164
- Place of performance
- UK
- Lots
- 1
- Notice number
- 010544-2025
- Reference
- ocds-h6vhtk-04f708
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
- 33690000Various medicinal products
Description
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infe…
Official publications
- FTS · 010544-2025 · 21 March 2025
Other tenders from NHS England
- RFI - National Asset Survey Programme
- NHS National Framework for Tafamidis
- Maternity and Neonatal Patient Reported Experience Measure (MatNeo PREM)
- Co-producing & evaluating interventions to support MMRV uptake Somali community
- NHS Chief Executive Readiness Assessment Model
- NHS Talking Therapies for Anxiety and Depression - RFI
- Chairs extended offer
- Soft Skills Course for GP IMGs (2026-2031)
- National Gambling Helpline
- Leadership Development to Support Engagement and Learning for Harmed Families
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £1,516,353,164.
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.